Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -145.10% is 10% above its 5-year average of -161.38%, near the high end of its 5-year range (-588.57%–-50.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.55% below its 12-month average of -134.91%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -145.10%.
RETURN ON INVESTED CAPITAL (ROIC)
-145.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-134.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-162.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-161.38%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.55%
CURRENT VS 3Y AVG
+10.96%
CURRENT VS 5Y AVG
+10.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-306.91%
vs the sector median at left
Lucid Diagnostics Inc.
Market Cap
$114.46M
Return on Invested Capital (ROIC)
-145.10%
TTM Avg
-134.91%
3Y Avg
-162.96%
5Y Avg
-161.38%
Market Cap
$113.89M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$113.77M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$115.67M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$112.94M
Return on Invested Capital (ROIC)
-62.15%
TTM Avg
-258.93%
3Y Avg
-258.93%
5Y Avg
-190.57%
Market Cap
$112.57M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$116.76M
Return on Invested Capital (ROIC)
-19.83%
TTM Avg
-23.34%
3Y Avg
-19.01%
5Y Avg
-18.39%
Market Cap
$117.76M
Return on Invested Capital (ROIC)
-50.67%
TTM Avg
-131.41%
3Y Avg
-97.53%
5Y Avg
-74.13%
Market Cap
$118.59M
Return on Invested Capital (ROIC)
-142.06%
TTM Avg
-89.80%
3Y Avg
-79.42%
5Y Avg
-61.57%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | $114.46M | -145.10% | -134.91% | -162.96% | -161.38% |
| Genelux Corporation (GNLX)vs › | $113.89M | -192.18% | -186.03% | -161.77% | -220.86% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | -0.05% | -44.27% | -81.25% | -78.53% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | -44.81% | -53.33% | -46.90% | -39.65% |
| Unicycive Therapeutics, Inc. (UNCY)vs › | $112.94M | -62.15% | -258.93% | -258.93% | -190.57% |
| Caribou Biosciences, Inc. (CRBU)vs › | $112.57M | -87.72% | -74.88% | -52.32% | -62.32% |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | -19.83% | -23.34% | -19.01% | -18.39% |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | -50.67% | -131.41% | -97.53% | -74.13% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | -142.06% | -89.80% | -79.42% | -61.57% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | -97.99% | -45.11% | -60.38% | -60.38% |
ROIC
-145.1%
ROE
-478.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -145.10% |
| 2026-03-31 | -159.95% |
| 2025-12-31 | -135.06% |
| 2025-09-30 | -95.68% |
| 2025-06-30 | -138.78% |
| 2025-03-31 | -164.50% |
| 2024-12-31 | -178.56% |
| 2024-09-30 | -243.31% |
| 2024-06-30 | -151.93% |
| 2024-03-31 | -178.32% |
| 2023-12-31 | -409.55% |
| 2023-09-30 | -296.73% |
| 2023-06-30 | -201.39% |
| 2023-03-31 | -154.79% |
| 2022-12-31 | -233.37% |
| 2022-09-30 | -183.14% |
| 2022-06-30 | -118.99% |
| 2022-03-31 | -75.16% |
| 2021-12-31 | -50.09% |
| 2021-06-30 | -588.57% |
